New Pan-Coronavirus Vaccine Passes Key Experiments, Demonstrates Protection
            Vaccine proved protective against COVID variants, including Omicron, in laboratory and primate studies
        
    Hemming Shares Why You Should Vote
If you haven't already noticed, we are in voting season. I love the energy of this time of year, though the barrage of advertisements, signs and frantic news coverage always threatens to temp
Lisa Criscione-Schreiber Receives ACR Distinguished Fellowship Program Director Award
            The award recognizes outstanding contributions in the mentoring and training of future rheumatologists.
        
    Internal Medicine Residency News, October 24th, 2022
From the Director
Last week of October/Doctober! ZaasFam had more traveling for kid soccer, big weekend of DukeFam reunion for a
One Foot in the Clinic, the Other in the Lab
            DOM faculty Rasheed Gbadegesin, MD, and Christopher Kontos, MD, share the importance of training future physician-scientists
        
    Keck uses APPLI project with goal to raise awareness for inflammatory breast cancer
            Valerie Keck, FNP-C, is a nurse practitioner at the Duke Outpatient Clinic (DOC) who specializes in primary care for the under-served community.
        
    Department of Medicine Welcomes New Faculty Members
            Faculty New to the Department of Medicine - October 1, 2021, through October 1, 2022
        
    Arif Kamal, MD, is making a difference with the American Cancer Society
            Arif Kamal, MD, HS’12, MHS’15, is highlighted as an alumni of the Duke University School of Medicine for his engagement and role with the American Cancer Society
        
    Developing New Tools to Fight Cancer
            For decades, medical cancer treatment has generally meant chemotherapy, radiation, or surgery, alone or in combination. But things are changing rapidly. Today, new approaches such as immunotherapies and targeted therapies are becoming available, with many more in research and development. In many cases, the new treatments are more effective, with fewer side effects.
        
    Study Finds No Benefit to Taking Fluvoxamine for COVID-19 Symptoms
            Medicine Faculty, Adrian Hernandez, MD, and Susanna Naggie, MD, are leading the trial being facilitated through the Duke Clinical Research Institute (DCRI)
        
     
             
             
             
             
             
             
             
             
            